Paediatric Urology · KIMS Secunderabad
Posterior Urethral Valve — Congenital Bladder Outlet Obstruction in Male Infants
Posterior urethral valve (PUV) is the most common cause of severe obstructive uropathy in male infants — a congenital anomaly in which an abnormal membranous fold (the valve) partially obstructs the posterior urethra, impeding urinary outflow from the bladder. PUV affects only males — approximately 1 in 5,000 to 8,000 male births. The obstruction causes a cascade of upstream damage: the bladder hypertrophies to generate the high pressure needed to overcome the obstruction, the ureters dilate (hydroureter), the kidneys dilate (hydronephrosis), and — in the most severe cases — the high pressure damages renal parenchyma during foetal development, causing renal dysplasia and permanent loss of functioning nephrons before birth.
PUV is one of the most important paediatric urological emergencies because: it is detectable antenatally (bilateral hydronephrosis on foetal ultrasound in a male foetus), it is treatable by cystoscopic valve ablation (a minimally invasive endoscopic procedure), and the long-term prognosis depends critically on the degree of renal damage that occurred during foetal development — damage that cannot be reversed after delivery. Approximately 25 to 30% of boys with PUV develop ESRD by adulthood, making it one of the leading causes of CKD in male children in India.
Antenatal and postnatal presentation
Antenatal detection (most common in developed centres)
Bilateral hydronephrosis detected on routine foetal ultrasound at 18 to 20 weeks. A dilated posterior urethra (the 'keyhole sign' on ultrasound — a dilated bladder communicating with the dilated proximal urethra) is highly specific for PUV. Oligohydramnios (reduced amniotic fluid from reduced foetal urine output) in severe cases. Foetal renal dysplasia (hyperechogenic kidneys on ultrasound — indicating permanent renal damage). When detected antenatally, delivery is planned at a tertiary paediatric urology centre with immediate postnatal management.
Postnatal presentation
A palpable, distended bladder in a male neonate that does not drain normally. Poor urinary stream — a dribbling, weak stream in a male infant. Urinary tract infection in the first weeks of life. Failure to thrive from uraemia. Abdominal distension from hydronephrosis.
Delayed diagnosis (older boys)
Some boys with milder PUV are not diagnosed until school age: urinary tract infections, day and night wetting beyond the normal age of continence, poor urinary stream, incomplete bladder emptying, or incidentally elevated creatinine on blood testing.
Diagnosis
Postnatal renal ultrasound
Bilateral hydronephrosis, dilated posterior urethra, thickened bladder wall (from hypertrophy). Performed in the first 24 to 48 hours after delivery if PUV is suspected antenatally.
VCUG (Voiding Cystourethrogram)
The definitive diagnostic investigation. Contrast is instilled into the bladder through a urethral catheter and fluoroscopic images are taken during filling and voiding. PUV appears as a dilated posterior urethra with an abrupt transition to a narrow anterior urethra at the valve level. VUR (present in 50% of PUV cases) is also assessed. VCUG performed within the first 24 to 48 hours of life after renal function is stabilised.
Serum creatinine and eGFR
At 1 month of age, the nadir creatinine (after maternal creatinine has cleared) gives the best estimate of the infant's own renal function. A nadir creatinine above 80 µmol/L at 1 month predicts a higher risk of long-term CKD.
Treatment
Urethral catheterisation — immediate decompression
A urethral catheter is placed immediately to drain the obstructed bladder, decompress the upper tracts, and stabilise kidney function before definitive valve ablation.
Cystoscopic valve ablation — the definitive treatment
Performed under general anaesthesia — a small cystoscope is passed into the urethra and the valve leaflets are ablated (cut or fulgurated) endoscopically, relieving the obstruction. Modern infant cystoscopes allow valve ablation in the first weeks of life, even in very small babies. At KIMS, cystoscopic valve ablation is performed by Dr. Neil Narendra Trivedi and the paediatric urology team.
Post-ablation monitoring
After valve ablation, the upper tracts are monitored for resolution of hydronephrosis (serial ultrasound every 3 months in the first year, then 6-monthly). VUR, if present, may resolve spontaneously after the obstruction is relieved or may require endoscopic correction (Deflux injection). Bladder function is assessed by urodynamic study — the hypertrophied, non-compliant bladder from years of obstruction may require long-term clean intermittent catheterisation (CIC) or anticholinergic therapy even after the valve is ablated.
Long-term CKD surveillance
Annual creatinine, eGFR, urine ACR, and blood pressure monitoring throughout childhood and into adulthood. 25 to 30% of PUV boys develop ESRD — kidney transplant evaluation begins at eGFR below 20 ml/min.
PUV is a condition where the long-term kidney outcome is determined largely by the degree of renal dysplasia that occurred in utero — not by the quality of postnatal surgical management alone. A boy with severe bilateral renal dysplasia (detected as hyperechogenic kidneys on antenatal ultrasound) may require kidney transplant in adolescence regardless of optimal surgical care. A boy with mild PUV and preserved renal development may reach adulthood with normal kidney function after valve ablation. Parental counselling at KIMS addresses this distinction clearly.
Book a Paediatric Urology Consultation at KIMS for PUV Assessment
Frequently Asked Questions — Posterior Urethral Valve
Yes — PUV is often detected on routine antenatal ultrasound performed at 18 to 20 weeks of gestation. Bilateral hydronephrosis in a male foetus, combined with a distended bladder and the 'keyhole sign' (dilated posterior urethra visible on ultrasound), should prompt referral to a foetal medicine and paediatric urology centre. Antenatal detection allows delivery to be planned at a centre with paediatric urology capacity and immediate postnatal management. However, antenatal diagnosis does not change the degree of renal dysplasia that has already occurred in utero — it only allows earlier postnatal intervention.
Approximately 25 to 30% of boys with PUV develop end-stage renal disease by adulthood — making PUV one of the most important causes of paediatric and young adult ESRD in India. The risk is higher in boys with more severe antenatal findings (bilateral renal dysplasia, oligohydramnios, nadir creatinine above 80 µmol/L at 1 month) and lower in boys with milder disease (unilateral hydronephrosis, preserved renal echogenicity, normal early creatinine). Kidney transplant remains the best long-term treatment for PUV-related ESRD — living related donor transplant from a parent or sibling (without PUV) gives the best outcomes. At KIMS, PUV boys are followed with annual kidney function and blood pressure monitoring throughout childhood.
Valve ablation relieves the urethral obstruction — the valve leaflets are divided and can no longer obstruct urine flow. However, ablation does not: reverse the renal dysplasia that occurred during foetal development (the most important determinant of long-term kidney function), correct the bladder dysfunction from years of high-pressure filling (the hypertrophied, non-compliant bladder may require long-term management), or reverse established VUR (which may need separate treatment). Valve ablation is the essential first step — but the long-term management of PUV is multidisciplinary (nephrology + urology) and continues throughout childhood and into adulthood.
The 'PUV bladder' refers to the abnormal bladder function that develops in boys with PUV — from years of high-pressure obstruction before and after birth. The detrusor muscle hypertrophies and loses its normal compliance — the bladder becomes stiff, contracts at low volumes (overactive), may not empty completely (high post-void residual), and has poor capacity. Even after valve ablation, the PUV bladder may continue to damage the upper tracts through high-pressure urine storage. Management: urodynamic study to characterise the bladder dysfunction, anticholinergic medications (oxybutynin) to reduce detrusor overactivity, clean intermittent catheterisation (CIC) for incomplete emptying, and in some cases bladder augmentation (ileocystoplasty) for a severely non-compliant contracted bladder.
KIMS Secunderabad — Dr. Neil Narendra Trivedi (MCh Urology KEM Mumbai, Member SIU, paediatric urology), cystoscopic valve ablation in neonates and infants, VCUG for diagnosis and VUR assessment, post-ablation renal and bladder surveillance, urodynamic study for PUV bladder dysfunction, Deflux injection for VUR, annual CKD monitoring programme, transplant evaluation for ESRD. NABH and NABL accredited. Call 040-4488-5000.